Adimab
Business Services · New Hampshire, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7 Lucent Dr, Lebanon, New Hampshire, 037...Phone Number
(603) 653-5775Website
www.adimab.comRevenue
$21.4 MillionIndustry
About Adimab
Adimab is a leading provider of a yeast-based antibody discovery and engineering platform designed to accelerate the development of therapeutic antibodies. The company offers a comprehensive suite of services including antibody discovery, engineering, and multispecific antibody development, aimed at improving patient outcomes. With over 140 biopharma partnerships and a proven track record of advancing therapeutic programs, Adimab is dedicated to supporting its partners through flexible collaboration models. Founded in 2007, Adimab has established itself as a trusted partner in the biopharma industry for the discovery and optimization of antibody therapeutics.Explore more
Adimab Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Adimab
Compare insights from companies similar to Adimab, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Adimab Tech Stack
A closer look at the technologies used by Adimab
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adimab
Sign Up For FreeTo access detailed company insights
Adimab is a leading provider of a yeast-based antibody discovery and engineering platform designed to accelerate the development of therapeutic antibodies. The company offers a comprehensive suite of services including antibody discovery, engineering, and multispecific antibody development, aimed at improving patient outcomes. With over 140 biophar... Read More
